Biotech Acquisition Co financial data

Industry
Blank Checks
Location
545 West 25 Th Street, 20 Th Floor, New York, NY
State of incorporation
Cayman Islands
Fiscal year end
December 31
Former names
Biotech Acquisition Company (to 9/21/2020)
Latest financial report
10-Q - Q3 2022 - Nov 22, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 9.06 %
Debt-to-equity -101 % +36%
Return On Equity -57.7 %
Return On Assets 4.76 %

Shares

Label TTM Value / Value Unit Change %
Common Stock, Value, Issued 575 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -4.36M USD -4831%
Net Income (Loss) Attributable to Parent 11M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.1K USD -96.7%
Assets, Current 95.3K USD -85.9%
Assets 231M USD +0.3%
Liabilities, Current 3.52M USD +881%
Liabilities 13.2M USD -35.7%
Retained Earnings (Accumulated Deficit) -13.1M USD +34%
Stockholders' Equity Attributable to Parent -13.1M USD +34%
Liabilities and Equity 231M USD +0.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -102K USD +88.2%
Net Cash Provided by (Used in) Financing Activities 115K USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.1K USD -96.7%
Preferred Stock, Shares Authorized 5M shares 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%